Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

870

Mechanism of ferroptosis resistance in cancer cells

Yuan Wang1,2, Guifang Yu1, Xin Chen1,2

  • 1Key Laboratory of Biological Targeting Diagnosis, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, Guangdong, China.

Cancer Drug Resistance (Alhambra, Calif.)
|December 3, 2024
PubMed

Insights

Ferroptosis, an iron-dependent cell death, shows promise against cancer but faces resistance. Understanding resistance mechanisms is key to developing effective ferroptosis-based cancer therapies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Ferroptosis is a regulated cell death pathway driven by iron accumulation and lipid peroxidation.
  • Inducing ferroptosis is a promising strategy for cancer treatment, showing potential against various malignancies.
  • Tumor resistance, both intrinsic and acquired, limits the efficacy of ferroptosis-based therapies.

Purpose of the Study:

  • To review mechanisms regulating ferroptosis sensitivity and resistance in cancer.
  • To summarize the therapeutic applications of ferroptosis inducers in oncology.
  • To explore signaling pathways contributing to ferroptosis resistance.

Main Methods:

  • Literature review of ferroptosis mechanisms and therapeutic strategies.
  • Analysis of signaling pathways involved in ferroptosis regulation and resistance.
  • Synthesis of current knowledge on overcoming ferroptosis resistance in cancer.

Main Results:

  • Ferroptosis sensitivity is modulated by lipid peroxidation, iron metabolism, and antioxidant pathways.
  • Key pathways contributing to ferroptosis resistance include glutathione (GSH), coenzyme Q (CoQ), NRF2 antioxidant response, and altered lipid/iron metabolism.
  • Diverse signaling pathways significantly influence cancer cell susceptibility or resistance to ferroptosis.

Conclusions:

  • Understanding the molecular basis of ferroptosis resistance is crucial for advancing cancer therapy.
  • Targeting resistance mechanisms offers a pathway to enhance the efficacy of ferroptosis inducers.
  • This review provides a foundation for developing novel anticancer strategies to overcome ferroptosis resistance.
Keywords:
Ferroptosis resistanceantioxidant defensescancerironlipid peroxidation

More Related Videos

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

411
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.5K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K